BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for XOMA Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 5:19 pm Sale |
2025-01-24 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 2,983,026 25.300% |
-650,717 (-17.91%) |
Filing |
| 2024-01-16 5:22 pm Purchase |
2024-01-11 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% |
103,200 (+2.92%) |
Filing |
| 2021-04-02 5:16 pm Sale |
2021-03-31 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 3,530,543 31.400% |
-651,700 (-15.58%) |
Filing |
| 2020-12-15 5:21 pm Unchanged |
2020-12-11 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.900% |
0 (Unchanged) |
Filing |
| 2020-10-09 5:20 pm Unchanged |
2020-10-07 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% |
0 (Unchanged) |
Filing |
| 2020-09-23 5:28 pm Purchase |
2020-09-21 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% |
156,086 (+3.88%) |
Filing |